Skip to main content
Top
Published in: Clinical Rheumatology 9/2017

01-09-2017 | Review Article

Histopathologic classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: achievements, limitations, and perspectives

Authors: Andrea Hinojosa-Azaola, Ariadna Jiménez-González

Published in: Clinical Rheumatology | Issue 9/2017

Login to get access

Abstract

Clinical and histological factors have been identified as predictors of early and late renal outcome in ANCA-associated vasculitides (AAV). The presence and severity of kidney involvement at diagnosis are associated with poor prognosis in both patient and renal survival. Histologic findings remain the gold standard for diagnosing patients with AAV. In order to quantify the extent of the morphological parameters in the renal biopsies and to identify the histopathological lesions that predict renal outcome, several scoring systems have been proposed to systematically assess kidney biopsies in AAV. Renal pathologists from an international working group proposed in 2010 a new histopathological classification. This scheme comprises four general categories, based on the predominance of the glomerular histological lesions: focal (≥50% normal glomeruli); crescentic (≥50% glomeruli with cellular crescents); mixed (<50% normal, <50% crescentic, <50% globally sclerotic glomeruli), and sclerotic (≥50% globally sclerotic glomeruli). This article reviews the background and the main studies that have validated the histopathologic classification of ANCA-associated glomerulonephritis, the conclusions derived from these studies, and the perspectives for the assessment of renal outcome in AAV.
Literature
1.
go back to reference Ereshefsky M (2001) Philosophy of biological classification. Encyclopedia of life sciences. John Wiley & Sons, New York Ereshefsky M (2001) Philosophy of biological classification. Encyclopedia of life sciences. John Wiley & Sons, New York
2.
go back to reference Bajema IM (2011) Pathological classification of anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis. Clin Exp Immunol 164(Suppl.1):14–16CrossRefPubMedPubMedCentral Bajema IM (2011) Pathological classification of anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis. Clin Exp Immunol 164(Suppl.1):14–16CrossRefPubMedPubMedCentral
3.
go back to reference Holle JU, Laudien M, Gross WL (2010) Clinical manifestations and treatment of Wegener’s Granulomatosis. Rheum Dis Clin N Am 36:507–526CrossRef Holle JU, Laudien M, Gross WL (2010) Clinical manifestations and treatment of Wegener’s Granulomatosis. Rheum Dis Clin N Am 36:507–526CrossRef
4.
go back to reference Chung SA, Seo P (2010) Microscopic polyangiitis. Rheum Dis Clin N Am 36:545–558CrossRef Chung SA, Seo P (2010) Microscopic polyangiitis. Rheum Dis Clin N Am 36:545–558CrossRef
5.
go back to reference Sinico RA, Di Toma L, Radice A (2013) Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 12:477–482CrossRefPubMed Sinico RA, Di Toma L, Radice A (2013) Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 12:477–482CrossRefPubMed
6.
go back to reference Chen M, Kallenberg CG, Zhao MH (2009) ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol 5:313–318CrossRefPubMed Chen M, Kallenberg CG, Zhao MH (2009) ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol 5:313–318CrossRefPubMed
7.
go back to reference Eisenberger U, Fakhouri F, Vanhille P et al (2005) ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant 20:1392–1399CrossRefPubMed Eisenberger U, Fakhouri F, Vanhille P et al (2005) ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant 20:1392–1399CrossRefPubMed
8.
go back to reference Hauer HA, Bajema IM, van Houwelingen HC et al (2002) Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 61:80–89CrossRefPubMed Hauer HA, Bajema IM, van Houwelingen HC et al (2002) Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 61:80–89CrossRefPubMed
9.
go back to reference Shah S, Havill J, Rahman MH et al (2016) A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonepritis. Clin Rheumatol 35:953–960CrossRefPubMed Shah S, Havill J, Rahman MH et al (2016) A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonepritis. Clin Rheumatol 35:953–960CrossRefPubMed
10.
go back to reference Bajema IM, Hagen EC, Hansen BE et al (1996) The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement. Nephrol Dial Transplant 11:1989–1995CrossRefPubMed Bajema IM, Hagen EC, Hansen BE et al (1996) The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement. Nephrol Dial Transplant 11:1989–1995CrossRefPubMed
11.
go back to reference Joh K, Muso E, Shigematsu H et al (2008) Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan. Clin Exp Nephrol 12:277–291CrossRefPubMed Joh K, Muso E, Shigematsu H et al (2008) Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan. Clin Exp Nephrol 12:277–291CrossRefPubMed
12.
go back to reference Rutgers A, Sanders JS, Stegeman CA, Kallenberg CG (2010) Pauci-immune necrotizing glomerulonephritis. Rheum Dis Clin N Am 36:559–572CrossRef Rutgers A, Sanders JS, Stegeman CA, Kallenberg CG (2010) Pauci-immune necrotizing glomerulonephritis. Rheum Dis Clin N Am 36:559–572CrossRef
13.
go back to reference Rhee RL, Hogan SL, Poulton CJ et al (2016) Trends in long-term outcomes among patients with antineutrophil cytoplasmic antibody-associated vasculitis with renal disease. Arthritis Rheum 68:1711–1720CrossRef Rhee RL, Hogan SL, Poulton CJ et al (2016) Trends in long-term outcomes among patients with antineutrophil cytoplasmic antibody-associated vasculitis with renal disease. Arthritis Rheum 68:1711–1720CrossRef
14.
go back to reference Kaplan-Pavlovcic S, Cerk K, Kveder R, Lindic J, Vizjak A (2003) Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients. Nephrol Dial Transplant 18(Suppl 5):v5–v7CrossRefPubMed Kaplan-Pavlovcic S, Cerk K, Kveder R, Lindic J, Vizjak A (2003) Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients. Nephrol Dial Transplant 18(Suppl 5):v5–v7CrossRefPubMed
15.
go back to reference Hauer HA, Bajema IM, Van Houwelingen HC et al (2002) Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis in 96 patients. Kidney Int 62:1732–1742CrossRefPubMed Hauer HA, Bajema IM, Van Houwelingen HC et al (2002) Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis in 96 patients. Kidney Int 62:1732–1742CrossRefPubMed
16.
go back to reference de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R et al (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17:2264–2274CrossRefPubMed de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R et al (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17:2264–2274CrossRefPubMed
17.
go back to reference de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R et al (2007) Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol 18:2189–2197CrossRefPubMed de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R et al (2007) Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol 18:2189–2197CrossRefPubMed
18.
go back to reference Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT (2005) Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant 20:96–104CrossRefPubMed Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT (2005) Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant 20:96–104CrossRefPubMed
19.
go back to reference Bajema IM, Hagen EC, Hermans J et al (1999) Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56:1751–1758CrossRefPubMed Bajema IM, Hagen EC, Hermans J et al (1999) Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56:1751–1758CrossRefPubMed
20.
go back to reference Hauer HA, Bajema IM, Hagen EC et al (2002) Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies. Nephrol Dial Transplant 17:587–596CrossRefPubMed Hauer HA, Bajema IM, Hagen EC et al (2002) Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies. Nephrol Dial Transplant 17:587–596CrossRefPubMed
21.
go back to reference Shigematsu H, Yamaguchi N, Koyama A (1998) Glomerulointerstitial events in rapidly progressive nephritic syndrome, with special reference to histologic grade and stage on the renal lesions. Clin Exp Nephrol 2:330–338CrossRef Shigematsu H, Yamaguchi N, Koyama A (1998) Glomerulointerstitial events in rapidly progressive nephritic syndrome, with special reference to histologic grade and stage on the renal lesions. Clin Exp Nephrol 2:330–338CrossRef
22.
go back to reference Vergunst CE, van Gurp E, Hagen EC et al (2003) EC/BCR project for ANCA-assay standardization. An index for renal outcome in ANCA-associated glomerulonephritis. Am J Kidney Dis 41:532–538CrossRefPubMed Vergunst CE, van Gurp E, Hagen EC et al (2003) EC/BCR project for ANCA-assay standardization. An index for renal outcome in ANCA-associated glomerulonephritis. Am J Kidney Dis 41:532–538CrossRefPubMed
23.
go back to reference Allison SJ (2010) ANCA-associated glomerulonephritis: a new histopathological classification. Nat Rev Nephrol 6:689CrossRefPubMed Allison SJ (2010) ANCA-associated glomerulonephritis: a new histopathological classification. Nat Rev Nephrol 6:689CrossRefPubMed
24.
go back to reference Jayne D, Rasmussen N, Andrassy K et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36–44CrossRefPubMed Jayne D, Rasmussen N, Andrassy K et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36–44CrossRefPubMed
25.
go back to reference Jayne DRW, Gaskin G, Rasmussen N et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjuntive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180–2188CrossRefPubMed Jayne DRW, Gaskin G, Rasmussen N et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjuntive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180–2188CrossRefPubMed
26.
go back to reference Berden AE, Ferrario F, Hagen EC et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21:1628–1636CrossRefPubMed Berden AE, Ferrario F, Hagen EC et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21:1628–1636CrossRefPubMed
27.
28.
go back to reference Geetha D, Poulton CJ, Hu Y et al (2014) Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans. Semin Arthritis Rheum 43:778–783CrossRefPubMed Geetha D, Poulton CJ, Hu Y et al (2014) Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans. Semin Arthritis Rheum 43:778–783CrossRefPubMed
29.
go back to reference Chang DY, Wu LH, Liu G, Chen M, Kallenberg CG, Zhao MH (2012) Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant 27:2343–2349CrossRefPubMed Chang DY, Wu LH, Liu G, Chen M, Kallenberg CG, Zhao MH (2012) Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant 27:2343–2349CrossRefPubMed
30.
go back to reference Ellis CL, Manno RL, Havill JP, Racusen LC, Geetha D (2013) Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome. BMC Nephrol 14:210CrossRefPubMedPubMedCentral Ellis CL, Manno RL, Havill JP, Racusen LC, Geetha D (2013) Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome. BMC Nephrol 14:210CrossRefPubMedPubMedCentral
31.
go back to reference Iwakiri T, Fujimoto S, Kitagawa K et al (2013) Validation of a newly porposed histopahological classification in Japanese patients with antineutrophil cytoplasmic antibody-assocaited glomerulonephritis. BMC Nephrol 14:125CrossRefPubMedPubMedCentral Iwakiri T, Fujimoto S, Kitagawa K et al (2013) Validation of a newly porposed histopahological classification in Japanese patients with antineutrophil cytoplasmic antibody-assocaited glomerulonephritis. BMC Nephrol 14:125CrossRefPubMedPubMedCentral
32.
go back to reference Haas M, Rastaldi MP, Fervenza FC (2014) Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. Kidney Int 85:779–793CrossRefPubMed Haas M, Rastaldi MP, Fervenza FC (2014) Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. Kidney Int 85:779–793CrossRefPubMed
33.
go back to reference Nohr E, Girard L, James M, Benediktsson H (2014) Validation of a histopathologic classification scheme for antineutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol 45:1423–1429CrossRefPubMed Nohr E, Girard L, James M, Benediktsson H (2014) Validation of a histopathologic classification scheme for antineutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol 45:1423–1429CrossRefPubMed
34.
go back to reference Andreiana I, Stancu S, Avram A, Taran L, Mircescu G (2015) ANCA positive crescentic glomerulonephritis outcome in a central east European cohort: a retrospective study. BMC Nephrol 16:90CrossRefPubMedPubMedCentral Andreiana I, Stancu S, Avram A, Taran L, Mircescu G (2015) ANCA positive crescentic glomerulonephritis outcome in a central east European cohort: a retrospective study. BMC Nephrol 16:90CrossRefPubMedPubMedCentral
35.
go back to reference Li ZY, Gou SJ, Chen M, Zhao MH (2013) Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center. Semin Arthritis Rheum 42:515–521CrossRefPubMed Li ZY, Gou SJ, Chen M, Zhao MH (2013) Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center. Semin Arthritis Rheum 42:515–521CrossRefPubMed
36.
go back to reference Togashi M, Komatsuda A, Nara M et al (2014) Validation of the 2010 histopathological classification of ANCA-associated glomerulonephritis in a Japanese single-center cohort. Mod Rheumatol 24:300–303CrossRefPubMed Togashi M, Komatsuda A, Nara M et al (2014) Validation of the 2010 histopathological classification of ANCA-associated glomerulonephritis in a Japanese single-center cohort. Mod Rheumatol 24:300–303CrossRefPubMed
37.
go back to reference Unlu M, Kiremitci S, Ensari A et al (2013) Pauci-immune necrotizing crescentic glomerulonephritis with crescentic and full moon extracapillary proliferation: clínico-pathologic correlation and follow-up study. Pathol Res Pract 209:75–82CrossRefPubMed Unlu M, Kiremitci S, Ensari A et al (2013) Pauci-immune necrotizing crescentic glomerulonephritis with crescentic and full moon extracapillary proliferation: clínico-pathologic correlation and follow-up study. Pathol Res Pract 209:75–82CrossRefPubMed
38.
go back to reference Hilhorst M, Wilde B, van Breda VP, van Paassen P, Cohen Tervaert JW, Limburg Renal Registry (2013) Estimating renal survival using the ANCA-associated GN classification. J Am Soc Nephrol 24:1371–1375CrossRefPubMedPubMedCentral Hilhorst M, Wilde B, van Breda VP, van Paassen P, Cohen Tervaert JW, Limburg Renal Registry (2013) Estimating renal survival using the ANCA-associated GN classification. J Am Soc Nephrol 24:1371–1375CrossRefPubMedPubMedCentral
39.
go back to reference Muso E, Endo T, Itabashi M et al (2013) Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts. Clin Exp Nephrol 17:659–662CrossRefPubMed Muso E, Endo T, Itabashi M et al (2013) Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts. Clin Exp Nephrol 17:659–662CrossRefPubMed
40.
go back to reference Hilhorst M, Wilde B, van Paassen P et al (2013) Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study. Nephrol Dial Transplant 28:373–379CrossRefPubMed Hilhorst M, Wilde B, van Paassen P et al (2013) Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study. Nephrol Dial Transplant 28:373–379CrossRefPubMed
41.
go back to reference Tanna A, Guarino L, Tam FW et al (2015) Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant 30:1185–1192CrossRefPubMed Tanna A, Guarino L, Tam FW et al (2015) Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant 30:1185–1192CrossRefPubMed
42.
go back to reference Quintana LF, Peréz NS, De Sousa E et al (2014) ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol Dial Transplant 29:1764–1769CrossRefPubMed Quintana LF, Peréz NS, De Sousa E et al (2014) ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol Dial Transplant 29:1764–1769CrossRefPubMed
43.
go back to reference Naidu GS, Sharma A, Nada R et al (2014) Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome. Rheumatol Int 34:1721–1727CrossRefPubMed Naidu GS, Sharma A, Nada R et al (2014) Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome. Rheumatol Int 34:1721–1727CrossRefPubMed
44.
45.
go back to reference Kristensen T, Gregersen JW, Krag SR et al (2016) The relation between histopathological classification and renal outcome, ANCA subtype and treatment regimens in ANCA-associated vasculitis. Clin Exp Rheumatol 34(Suppl 97):S105–S110PubMed Kristensen T, Gregersen JW, Krag SR et al (2016) The relation between histopathological classification and renal outcome, ANCA subtype and treatment regimens in ANCA-associated vasculitis. Clin Exp Rheumatol 34(Suppl 97):S105–S110PubMed
46.
go back to reference Ford SL, Polkinghorne KR, Longano A et al (2014) Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis. Am J Kidney Dis 63:227–235CrossRefPubMed Ford SL, Polkinghorne KR, Longano A et al (2014) Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis. Am J Kidney Dis 63:227–235CrossRefPubMed
47.
go back to reference Córdova-Sánchez BM, Mejía-Vilet JM, Morales-Buenrostro LE, Loyola-Rodríguez G, Uribe-Uribe NO, Correa-Rotter R (2016) Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvment. Clin Rheumatol. doi:10.1007/s10067-016-3195-z Córdova-Sánchez BM, Mejía-Vilet JM, Morales-Buenrostro LE, Loyola-Rodríguez G, Uribe-Uribe NO, Correa-Rotter R (2016) Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvment. Clin Rheumatol. doi:10.​1007/​s10067-016-3195-z
48.
go back to reference Noone DG, Twilt M, Hayes WN et al (2014) The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood. Clin J Am Soc Nephrol 9:1684–1691CrossRefPubMedPubMedCentral Noone DG, Twilt M, Hayes WN et al (2014) The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood. Clin J Am Soc Nephrol 9:1684–1691CrossRefPubMedPubMedCentral
49.
go back to reference Berden AE, Jones RB, Erasmus DD et al (2012) Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy. J Am Soc Nephrol 23:313–321CrossRefPubMed Berden AE, Jones RB, Erasmus DD et al (2012) Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy. J Am Soc Nephrol 23:313–321CrossRefPubMed
50.
go back to reference Rahmattulla C, de Lind van Wijngaarden RA, Berden AE et al (2015) Renal function and ear, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials. Rheumatology (Oxford) 54:899–907CrossRef Rahmattulla C, de Lind van Wijngaarden RA, Berden AE et al (2015) Renal function and ear, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials. Rheumatology (Oxford) 54:899–907CrossRef
51.
go back to reference Sethi S, Haas M, Markowitz GS et al (2016) Mayo Clinic/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting on GN. J Am Soc Nephrol 27:1278–1287CrossRefPubMed Sethi S, Haas M, Markowitz GS et al (2016) Mayo Clinic/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting on GN. J Am Soc Nephrol 27:1278–1287CrossRefPubMed
52.
go back to reference Glassock RJ (2004) Reclassification of lupus glomerulonephritis: back to the future. J Am Soc Nephrol 15:501–503CrossRefPubMed Glassock RJ (2004) Reclassification of lupus glomerulonephritis: back to the future. J Am Soc Nephrol 15:501–503CrossRefPubMed
Metadata
Title
Histopathologic classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: achievements, limitations, and perspectives
Authors
Andrea Hinojosa-Azaola
Ariadna Jiménez-González
Publication date
01-09-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3721-7

Other articles of this Issue 9/2017

Clinical Rheumatology 9/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.